Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jane Ripley"'
Autor:
Sara Mastaglio, Eric Wong, Travis Perera, Jane Ripley, Piers Blombery, Mark J. Smyth, Rachel Koldej, David Ritchie
Publikováno v:
Blood Advances, Vol 2, Iss 4, Pp 335-346 (2018)
Abstract: Natural killer (NKs) cells provide rapid responses to viral-infected and malignant cells, including acute myeloid leukemia (AML) blasts. The balance among inhibitory and activating signals, delivered by multiple interactions between ligands
Externí odkaz:
https://doaj.org/article/83212ce8ab8846cbbb2ff91154a41b2b
Collaboration Begins with YouEveryone knows collaboration creates high performing teams and organizations—and with today's diverse, globalized workforce it's absolutely crucial. Yet it often doesn't happen because people and groups typically believ
Autor:
Lynette Chee, David Ritchie, Mandy Ludford‐Menting, Jane Ripley, Jessica Chung, Daniel Park, Sam Norton, Melita Kenealy, Rachel Koldej
Publikováno v:
European Journal of Haematology. 108:342-353
Myelodysplastic syndromes (MDS) are characterised by ineffective haematopoiesis. Although hypomethylating agents (HMA) have improved survival in higher-risk MDS, most patients eventually succumb to progressive disease. Utilising samples collected pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1dca8f8ffbd8e23588bff0f08f9f817
https://doi.org/10.1111/ejh.13742
https://doi.org/10.1111/ejh.13742
Autor:
Mark J. Smyth, Rachel Koldej, Sara Mastaglio, Piers Blombery, Jane Ripley, Eric Wong, David Ritchie, Travis Perera
Publikováno v:
Blood Advances. 2:335-346
Natural killer (NKs) cells provide rapid responses to viral-infected and malignant cells, including acute myeloid leukemia (AML) blasts. The balance among inhibitory and activating signals, delivered by multiple interactions between ligands on target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92ccd2d299e199ec321722cdca4aaef
https://doi.org/10.1182/bloodadvances.2017015230
https://doi.org/10.1182/bloodadvances.2017015230
Autor:
Rachel Koldej, Jane Ripley, Daniel J. Park, Lynette C.Y. Chee, Mandy J. Ludford-Menting, David A. Ritchie, Jessica Chung, Melita Kenealy
Publikováno v:
Cancer Research. 78:1548-1548
Background: Hypomethylating agents (HMA) used in higher-risk myelodysplastic syndromes (MDS) improve survival but HMA-failure has a poor prognosis. Abnormal bone marrow (BM) colony-forming units (CFUs) persist in treated MDS patients despite achievem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::089651ee04f590fad21f300dc7b23d69
https://doi.org/10.1158/1538-7445.am2018-1548
https://doi.org/10.1158/1538-7445.am2018-1548
Abstract A019: Prognostic significance of natural killer ligand expression in acute myeloid leukemia
Autor:
Mark J. Smyth, Christopher J. Chan, David Ritchie, Paul J Neeson, Travis Perera, Jane Ripley, Rachel Koldej
Publikováno v:
Cancer Immunology Research. 4:A019-A019
Immune evasion is a hallmark of persistence and progression of many haematological and non-haematological tumors. Progression of acute myeloid leukaemia (AML) post allogeneic stem cell transplant is often associated with evidence of immune escape and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ddd52b38b5a1c7ad1a33cfd5951c366
https://doi.org/10.1158/2326-6074.cricimteatiaacr15-a019
https://doi.org/10.1158/2326-6074.cricimteatiaacr15-a019
Autor:
Mastaglio, Sara, Wong, Eric, Perera, Travis, Jane, Ripley, Blombery, Piers, Koldej, Rachel, Ritchie, David
Publikováno v:
Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p3948-3948, 1p